Last 12 months
Inside the activity.
0 purchase rows · 214 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 14 |
| May 2026 | 0 | 28 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 36 |
| Aug 2026 | 0 | 44 |
| Sep 2026 | 0 | 15 |
| Oct 2026 | 0 | 6 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2024 Filed Apr 5, 2024 20:37 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 386 | $21.70 | $8,376.20 |
DisclosureSEC source: 0001447362-24-000035 · wk-form4_1712349465.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk Disclosed balance after: 10,071 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.28 to $22.15, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:37 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,212 | $21.70 | $26,300.40 |
DisclosureSEC source: 0001447362-24-000035 · wk-form4_1712349465.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust Disclosed balance after: 76,227 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.28 to $22.15, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:37 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,212 | $21.70 | $26,300.40 |
DisclosureSEC source: 0001447362-24-000035 · wk-form4_1712349465.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold Descendants 2020 Trust Disclosed balance after: 87,330 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.28 to $22.15, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries. Read SEC document |
| April 03, 2024 Filed Apr 5, 2024 20:37 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,368 | $21.70 | $51,385.60 |
DisclosureSEC source: 0001447362-24-000035 · wk-form4_1712349465.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,365 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.28 to $22.15, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 26, 2024 Filed Mar 28, 2024 20:43 UTC |
Cotton RodneyDirector
|
GrantRestricted Stock Units · Derivative | 15,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000033 · wk-form4_1711658581.xml · derivative · entry 1 Cotton Rodney · CIK 0002015732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,988 Underlying: Common Stock · 15,988 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on March 26, 2025. F2 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on March 26, 2025. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 12 | $20.70 | $248.40 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 14 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold Disclosed balance after: 10,455 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 12 | $20.70 | $248.40 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 13 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold Disclosed balance after: 10,455 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F7 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 12 | $20.70 | $248.40 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 12 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold Disclosed balance after: 10,455 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F6 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 11 | $20.70 | $227.70 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 11 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk Disclosed balance after: 10,457 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 37 | $20.70 | $765.90 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 10 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust Disclosed balance after: 77,439 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 37 | $20.70 | $765.90 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 9 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold Descendants 2020 Trust Disclosed balance after: 88,542 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 73 | $20.70 | $1,511.10 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 8 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,733 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 374 | $20.27 | $7,580.98 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 7 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold Disclosed balance after: 10,467 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 374 | $20.27 | $7,580.98 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 6 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold Disclosed balance after: 10,467 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 374 | $20.27 | $7,580.98 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 5 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold Disclosed balance after: 10,467 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 375 | $20.27 | $7,601.25 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk Disclosed balance after: 10,468 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,175 | $20.27 | $23,817.25 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust Disclosed balance after: 77,476 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,175 | $20.27 | $23,817.25 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold Descendants 2020 Trust Disclosed balance after: 88,579 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 21:16 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,295 | $20.27 | $46,519.65 |
DisclosureSEC source: 0001447362-24-000031 · wk-form4_1711142198.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,806 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.07 to $20.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 388 | $20.77 | $8,058.76 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 7 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold Disclosed balance after: 10,841 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F8 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 388 | $20.77 | $8,058.76 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 6 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold Disclosed balance after: 10,841 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO John Derek Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 388 | $20.77 | $8,058.76 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 5 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold Disclosed balance after: 10,841 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F6 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 388 | $20.77 | $8,058.76 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 4 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk Disclosed balance after: 10,843 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk of which the Reporting Person is the trustee and his child is the beneficiary. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,222 | $20.77 | $25,380.94 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 3 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Derek Maetzold 2020 Irrevocable Trust Disclosed balance after: 78,651 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 1,222 | $20.77 | $25,380.94 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Indirect · By The Maetzold Descendants 2020 Trust Disclosed balance after: 89,754 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 21:18 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 2,372 | $20.77 | $49,266.44 |
DisclosureSEC source: 0001447362-24-000029 · wk-form4_1710191892.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,101 F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, The Maetzold 2018 Remainder Trust f/b/o Emily Carol Kirk, The Maetzold 2018 Remainder Trust f/b/o Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust f/b/o John Derek Maetzold, and The Maetzold 2018 Remainder Trust f/b/o Peter Douglas Maetzold on December 5, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.55 to $21.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 22:58 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 10,686 | $3.72 Strike: $3.72 | $39,751.92 |
DisclosureSEC source: 0001447362-24-000021 · wk-form4_1709765883.xml · derivative · entry 11 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,686 shares Expires 2024-03-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The shares subject to the option are fully vested. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 22:58 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
SaleCommon Stock | 4,131 | $21.41 | $88,461.23 |
DisclosureSEC source: 0001447362-24-000021 · wk-form4_1709765883.xml · nonDerivative · entry 2 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,473 Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 22:58 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
Exercise / conversionCommon Stock | 10,686 | $3.72 | $39,751.92 |
DisclosureSEC source: 0001447362-24-000021 · wk-form4_1709765883.xml · nonDerivative · entry 1 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:07 UTC |
Juvenal Tobin WChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 55,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000027 · wk-form4_1709766451.xml · derivative · entry 1 Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,243 Underlying: Common Stock · 55,243 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:04 UTC |
Oelschlager Kristen MChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 55,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000025 · wk-form4_1709766226.xml · derivative · entry 1 Oelschlager Kristen M · CIK 0001856565 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,243 Underlying: Common Stock · 55,243 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:00 UTC |
Stokes FrankChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 48,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000023 · wk-form4_1709766033.xml · derivative · entry 1 Stokes Frank · CIK 0001782815 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,744 Underlying: Common Stock · 48,744 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:58 UTC |
MAETZOLD DEREK JDirector · Pres. & Chief Exec. Officer
|
GrantRestricted Stock Units · Derivative | 124,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001447362-24-000021 · wk-form4_1709765883.xml · derivative · entry 10 MAETZOLD DEREK J · CIK 0001239501 · Director · Pres. & Chief Exec. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,437 Underlying: Common Stock · 124,437 shares Expires not disclosed F8 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock. F9 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. F9 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:52 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 2,262 | $21.28 | $48,135.36 |
DisclosureSEC source: 0001447362-24-000019 · wk-form4_1709765534.xml · nonDerivative · entry 6 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust Disclosed balance after: 25,915 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $21.05 to $21.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:52 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 2,262 | $21.28 | $48,135.36 |
DisclosureSEC source: 0001447362-24-000019 · wk-form4_1709765534.xml · nonDerivative · entry 5 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust Disclosed balance after: 25,907 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $21.05 to $21.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:52 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 2,099 | $21.28 | $44,666.72 |
DisclosureSEC source: 0001447362-24-000019 · wk-form4_1709765534.xml · nonDerivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By LLC Disclosed balance after: 49,909 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $21.05 to $21.43, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:52 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 5,705 | $20.44 | $116,610.20 |
DisclosureSEC source: 0001447362-24-000019 · wk-form4_1709765534.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust Disclosed balance after: 28,177 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.03 to $20.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:52 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 5,701 | $20.44 | $116,528.44 |
DisclosureSEC source: 0001447362-24-000019 · wk-form4_1709765534.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust Disclosed balance after: 28,169 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.03 to $20.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:52 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 5,294 | $20.44 | $108,209.36 |
DisclosureSEC source: 0001447362-24-000019 · wk-form4_1709765534.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By LLC Disclosed balance after: 52,008 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.03 to $20.99, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:49 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 708 | $23.20 | $16,425.60 |
DisclosureSEC source: 0001447362-24-000012 · wk-form4_1707515336.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust Disclosed balance after: 33,882 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.05 to $23.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:49 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 708 | $23.20 | $16,425.60 |
DisclosureSEC source: 0001447362-24-000012 · wk-form4_1707515336.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust Disclosed balance after: 33,870 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.05 to $23.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:49 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 658 | $23.20 | $15,265.60 |
DisclosureSEC source: 0001447362-24-000012 · wk-form4_1707515336.xml · nonDerivative · entry 1 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By LLC Disclosed balance after: 57,302 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $23.05 to $23.71, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 3,364 | $23.63 | $79,491.32 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 9 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust Disclosed balance after: 34,590 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F7 · price: This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 3,362 | $23.63 | $79,444.06 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 8 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust Disclosed balance after: 34,578 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F7 · price: This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 3,121 | $23.63 | $73,749.23 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 7 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By LLC Disclosed balance after: 57,960 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F7 · price: This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 931 | $23.42 | $21,804.02 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 6 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust Disclosed balance after: 37,954 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 930 | $23.42 | $21,780.60 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 5 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust Disclosed balance after: 37,940 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 863 | $23.42 | $20,211.46 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 4 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By LLC Disclosed balance after: 61,081 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F6 · price: This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · ownership.nature: Held by BioBrit, LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 2,964 | $22.74 | $67,401.36 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 3 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Annette Bradbury Irrecovable Descendant's Trust Disclosed balance after: 38,885 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F5 · ownership.nature: Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:19 UTC |
BRADBURY DANIELDirector
|
SaleCommon Stock | 2,963 | $22.74 | $67,378.62 |
DisclosureSEC source: 0001447362-24-000010 · wk-form4_1707340729.xml · nonDerivative · entry 2 BRADBURY DANIEL · CIK 0001236397 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Daniel Bradbury Irrecovable Descendant's Trust Disclosed balance after: 38,870 F1 · kind: The transaction on this Form 4 was made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC, The Daniel M. Bradbury Irrevocable Descendants' Trust and The Annette E. Bradbury Irrevocable Descendants' Trust on August 22, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · ownership.nature: Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.